In the present study, we also confirmed CXCL10 to be one of the most significantly UR cytokines in all SS patient datasets, as compared to other cytokines such as IL-6, IL-8 and CCL5. CXCL10 is known to increase MMP9 expression [47, 57]. This evidence concerns the gene IL6 and synovial sarcoma.